Bioinformatics
バイオインフォマティクス
Transform Extensive Data into Actionable Insights with Advanced Computational Tools for Pharma R&D
製薬R&D向け先端の計算ツールで、膨大なデータを実用的なインサイトに変換
2025年4月2日〜4日 米国東部標準時(EDT)
4月2日(水)
Registration Open8:00 am
Recommended Pre-Conference Workshops and Symposia*9:00 am
On Wednesday, April 2, 2025, Cambridge Healthtech Institute is pleased to offer five pre-conference Workshops scheduled across two time slots (9:00 am–12:00 pm and 1:15–4:15 pm) and three Symposia from 9:00 am–4:20 pm. All are designed to be instructional, interactive, and provide in-depth information on a specific topic. They allow for one-on-one interaction and provide a great way to explain more technical aspects that would otherwise not be covered during the main conference tracks that take place Thursday–Friday.
*Separate registration required. See details on the Symposia here and details on the Workshops here.
From Bytes to Breakthroughs: Generative AI Driving the Future of Life Sciences and Healthcare
Subha Madhaven, Vice President and Head, AI/ML, Quantitative and Digital Sciences, Global Metrics and Data Management, Pfizer Inc.
Generative AI has the potential to transform life sciences and deliver unprecedented insights, automation, and efficiency. But is it? This keynote panel brings together leaders from biopharma, healthcare, and emerging tech who are leveraging AI to advance drug discovery, diagnostics, and patient care. Panelists will share their own case studies and real-world applications and discuss how they’ve tackled challenges—both technical and cultural. Look beyond the hype curve to see how this technology is really being used now and where the next opportunities lie.
Welcome Reception in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)6:10 pm
The Bio-IT Kickoff Reception is a reunion—reconnect with friends, explore cutting-edge research, and celebrate innovation! Enjoy poster presentations, networking, and vote for the Best of Show and Poster awards.
Close of Day7:25 pm
4月3日(木)
Registration Open7:00 am
AI-POWERED PLATFORMS IN DRUG DISCOVERY: TACKLING ANTIBIOTIC RESISTANCE AND AGING THERAPEUTICS
創薬におけるAI活用のプラットフォーム:抗生剤耐性と老化治療への取り組み
Deep Learning for Antibiotic Discovery
James J. Collins, PhD, Termeer Professor, Medical Engineering & Science, Massachusetts Institute of Technology
In this presentation, we highlight the Antibiotics-AI Project, which is a multi-disciplinary, innovative research program that is leveraging MIT's strengths in artificial intelligence, bioengineering, and the life sciences to discover and design novel classes of antibiotics. The Antibiotics-AI Project is focused on developing, integrating, and implementing deep learning models and chemogenomic screening approaches: (1) to predict novel antibiotics from expansive chemical libraries with diverse properties, (2) to design de novo novel antibiotics based on learned structural and functional properties of existing and newly discovered antibiotics, and (3) to identify, using explainable deep learning models, the chemical structures and molecular mechanisms underlying the newly discovered and/or designed antibiotics. With these deep learning approaches, we are utilizing multi-scale computation to embrace and harness the complexity of biology and chemistry, so as to discover, design, and develop new classes of antibiotics, up through preclinical studies. Our platform has been designed so that it can be utilized and applied in a rapid fashion to emerging and re-emerging bacterial pathogens, including multidrug-resistant (MDR) bacteria and extensively drug-resistant (XDR) bacteria.
Coffee Break in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)9:30 am
Start your morning with coffee, connections, and cutting-edge research! Enjoy poster presentations, network in the Exhibit Hall, vote for awards, and a chance at a fabulous raffle prize!
Organizer's Welcome Remarks10:15 am
ADVANCES IN AI-DRIVEN BIOINFORMATICS: INTEGRATIVE GENOMIC ANALYSIS FOR PRECISION MEDICINE AND ONCOLOGY
AIドリブンのバイオインフォマティクスの進歩:精密医療とオンコロジー向け統合ゲノム解析
Empowering Precision Medicine with VarSeq: A Comprehensive Platform for Genomic Analysis
Andreas Scherer, PhD, President and CEO, Golden Helix, Inc.
This presentation highlights VarSeq’s advanced genomic analysis capabilities, including precise CNV calling for whole exome sequencing, long-read support with allele phasing, and VSPGx for pharmacogenomics, adhering
to CPIC and FDA standards. We will discuss benchmark data, case studies, and VarSeq’s “Bring Your Own Cloud” flexibility for deployment on AWS, Azure, Google Cloud, or on-premises, making it a versatile tool for precision
medicine.
CAMP (The Core Analysis Modular Pipeline): Software Design for Integrative Exploration of Large Metagenomics Datasets
Iman Hajirasouliha, PhD, Associate Professor and Co-Director of the Tri-Institutional Computational Biology and Medicine PhD Program, Joan & Sanford I. Weill Medical College of Cornell University
Computational analysis of large-scale metagenomics sequencing datasets have proven to be both incredibly valuable for extracting isolate-level taxonomic, and functional insights from complex microbial communities. However, due to an ever-expanding ecosystem of metagenomics-specific methods and file-formats, designing studies which implement seamless and scalable end-to-end workflows, and exploring the massive amounts of output data have become studies unto themselves. To address the gap in easily extensible yet robustly distributable metagenomics workflows, we have developed a module-based metagenomics analysis system: "Core Analysis Metagenomics Pipeline" (CAMP) along with a standardized module and working directory architecture.
Advancing Comprehensive and Accurate Secondary Analysis for Long and Short Read Data Integration
Brendan Gallagher, Head, Business Development, Sentieon, Inc.
New “hybrid” secondary analysis pipeline combining 30x short-read sequencing and 10x PacBio HiFi sequencing resulting in possibly the most accurate genome analysis available. Benchmarking with a 30x NovaSeq and 10x
HiFi coverage, we record only 5,909/1,665 total (SNP/indel) errors relative to the GIAB v4.2.1 HG002 truthset. The pipeline reduces variant calling errors by 74% compared to DeepVariant on 30x NovaSeq data and 26%
relative to DV with 30x HiFi data.
Presentation to be Announced (Sponsorship Opportunity Available)12:10 pm
Presentation to be Announced (Sponsorship Opportunity Available)12:40 pm
Session Break and Transition to Lunch12:55 pm
Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own1:05 pm
Refreshment Break in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)1:35 pm
Bio-IT's hall is bigger than ever—one break won’t cut it! Enjoy dessert and coffee after lunch, explore booths and posters, vote for awards, and participate in our raffle for a chance to win a prize!
INNOVATIVE PLATFORMS IN BIOINFORMATICS: ADVANCING DATA INTEGRITY AND WORKFLOW OPTIMIZATION
バイオインフォマティクスにおける革新的プラットフォーム:データインテグリティとワークフローの最適化を推進
Chairperson's Remarks (Sponsorship Opportunity Available)2:25 pm
TakOmics: A FAIR Multiomics Data Management and Analytics Platform
Felix Francis, PhD, Senior Manager, Data Management & Analytics, Data Sciences Institute, Takeda
TakOmics is a FAIR multi-omics data management and analytics platform designed to meet the intricate demands of omics data workflows. TakOmics automates data transfer processes, centralizes data management, and introduces
a data steward role to ensure data integrity and provides enhanced bioinformatics capabilities aimed at streamlining pipeline development and validation. The platform also explores simplifying the validation processes
in GxP compliant environments, ensuring high standards of data management. TakOmics represents a significant leap towards integrating advanced analytics and data stewardship within multiomics research, fostering a
more efficient, secure, and collaborative scientific environment.
Data-Driven Modeling vs. Model-Driven Data Analytics: A Paradigm Shift in Women’s Health
Big Data and AI/ML methods are revolutionizing drug development, disease diagnosis, and treatment by identifying patterns within integrated datasets. However, these methods often rely on initial models that shape what
data is collected, potentially limiting discovery. Model-driven data analytics reverses this process, identifying gaps in existing datasets and resolving conflicts. This presentation explores how this innovative approach
is driving new data collection to address complex issues in women’s health.
Presentation to be Announced (Sponsorship Opportunity Available)4:00 pm
Best of Show Awards Reception in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)4:30 pm
Unwind with colleagues at our lively reception! Explore posters, vote for the best, network with exhibitors, enjoy a drink, and try to win a raffle prize. Celebrate Best of Show winners!
Close of Day5:45 pm
4月4日(金)
Registration Open7:00 am
Quick Bytes & Networking Breakfast—Lifted Rooftop Restaurant & Bar (Sponsorship Opportunity Available)7:00 am
Start your morning with ‘Quick Bytes & Networking’! Enjoy a cozy restaurant-style setting, quick bites, and speed networking. Connect, converse, and energize your Bio-IT experience before the plenary keynote!
Innovative Practices Awards: Excellence in Technological Innovation
Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News
The Innovative Practices Awards recognizes and celebrates technology innovation in the life sciences. Bio-IT World is currently accepting entries for the 2025 Innovative Practices Awards, a competition designed to recognize
partnerships and projects pushing our industry forward. Winners will be announced in mid-March 2025, recognized during the Friday, April 4 Plenary Keynote Program, and scheduled to give a podium presentation about
their project during the conference. For more details about the Awards and to submit an application, visit www.bioitworldexpo.com/innovativepractices.
ADVANCING DRUG DISCOVERY AND HEALTHCARE THROUGH DATA-DRIVEN INNOVATION: FROM GENOMICS TO THERAPEUTICS
データドリブンのイノベーションによる創薬とヘルスケアの進歩:ゲノミクスから治療まで
Scaling Genomic Medicine: Transforming Newborn Screening through Informatics and Innovation
Robert C. Green, MD, MPH, Professor and Director of Genomes2People Research, Mass General Brigham, Broad Institute, Ariadne Labs and Harvard Medical School
The BabySeq Project has pioneered the integration of genomic sequencing into newborn and childhood screening, uncovering unexpected risk variants and transforming healthcare delivery. This keynote explores the groundbreaking
progress in genomic medicine, featuring real-world stories of families impacted by these discoveries. Learn about the informatics challenges and innovative solutions required to scale genomic screening for national
and global implementation, reshaping the future of precision medicine.
Unlocking the Power of Machine Learning and Data-at-Scale to Deliver with Speed the Best Therapeutic Candidates
Justin M. Scheer, PhD, Vice President In Silico Discovery & Head, Molecular Computational Team, Johnson & Johnson Innovative Medicine
The challenges of high costs, lengthy timelines, and significant attrition have prompted our industry to integrate AI/ML into all aspects of the business. This presentation highlights J&J's strategic investments
in AI/ML technologies to enhance the drug discovery processes, including molecule design and optimization. By investing in these technologies with a modality agnostic approach, J&J aims to tackle the hardest targets
in drug discovery, ultimately increasing the success rate of delivering better molecules faster.
Coffee Break in the Exhibit Hall with Poster Competition Winners Announced (Sponsorship Opportunity Available)9:45 am
Bio-IT is all about connections! Explore booths, award-winning posters, and network with clients, colleagues, and exhibitors. Grab coffee, build relationships, and stay for a chance to win a raffle prize!
Organizer's Remarks10:30 am
AI-ENHANCED BIOINFORMATICS: CLOUD-POWERED PLATFORMS AND OPEN-SOURCE TOOLS FOR ADVANCING DRUG DISCOVERY AND PUBLIC HEALTH
AI強化のバイオインフォマティクス:創薬・公衆衛生を推進するクラウドベースのプラットフォームとオープンソースツール
Chairperson's Remarks (Sponsorship Opportunity Available)10:35 am
OSPREY, an Open Science Platform for Better Decision-Making in Public Health
Brigitte E. Raumann, Product Manager, University of Chicago, Globus
The COVID-19 pandemic necessitated unprecedented scientific collaboration, leveraging relationships among domain experts, mathematical modelers, and scientific computing specialists to inform public health decisions.
Among the myriad outcomes from this collaboration is OSPREY, an open science platform for robust epidemic analysis. We will describe the development and use of the OSPREY prototype and work planned to make it a public
resource for epidemiologic modeling and analysis.
Innovating Drug Discovery with Cloud-Powered Cryo-EM and Structural Biology Tools
Piotr Sliz, PhD, Associate Professor & Vice President & Chief Research Information Officer, Biological Chemistry & Molecular Pharmacology, Harvard Medical School
Harvard Medical School, in collaboration with AWS, has developed a scalable, cloud-powered Cryo-EM infrastructure using SBGrid’s suite of 400+ structural biology tools. This innovative approach enables widespread access
to high-performance computing for drug discovery, democratizing advanced data analysis across academic, public sector, and biopharma institutions. By deploying this technology at underfunded research centers, such
as Meharry Medical College, this initiative enables breakthroughs in drug discovery and ultimately new treatments for patients.
An Open-Source Platform for Quantitative Interactomics
Julian West, Graph Database Architect, AbbVie, Inc.
Advances in Power Computing have been tightly-coupled with applications such as AI, but not so much with Dynamical Modeling for Systems Biology. We want to put to good use the Long Attention Span of open-source development,
for an ambitious project meant to grow alongside advances in power computing and in interactomics data.
Presentation to be Announced (Sponsorship Opportunity Available)12:10 pm
Session Break and Transition to Lunch1:10 pm
Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own1:20 pm
Refreshment Break in the Exhibit Hall with Last Chance for Poster Viewing (Sponsorship Opportunity Available)1:50 pm
Feeling tired? Recharge during the final Networking Exhibit Hall break! Visit booths, explore posters, connect with peers, and turn in your Game Cards for a chance to win a raffle prize.
DRIVING AI INNOVATION: BEST PRACTICES FOR IMPLEMENTATION IN BIOPHARMA
AIイノベーションの推進:バイオファーマにおける導入のベストプラクティス
Chairperson's Remarks (Sponsorship Opportunity Available)2:30 pm
Unlocking AI Potential: Best Practices for Implementation and Management
Petrina Kamya, PhD, Global Head of AI Platforms & Vice President, Insilico Medicine; President, Insilico Medicine Canada
As AI transforms drug discovery, development, and precision medicine, understanding the business operations behind these advancements is essential. This session will cover critical aspects such as AI tool selection, project
scoping, budget management, and prioritization amid evolving regulations. Gain insights from real-world case studies on successful AI deployment, with strategies to navigate regulatory risks while ensuring cost-effectiveness.
Join us for a dynamic discussion to harness AI’s full potential in life sciences innovation.
Close of Conference4:05 pm
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。